| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.35 | 0.01 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.4 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.02 |